Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2014 R21 RFA-CA-13-003 VARANI, JAMES UNIVERSITY OF MICHIGAN ISOLATION AND IN VITRO MAINTENANCE OF INTACT COLONIC CRYPTS FROM NORMAL HUMAN COL Complete
2017 R33 RFA-CA-16-002 LEVENSON, RICHARD M. UNIVERSITY OF CALIFORNIA AT DAVIS Cancer histology and QC via MUSE: Sample-sparing UV surface-excitation microscopy Complete
2001 R21 PAR-99-102 SPEICHER, DAVID W. WISTAR INSTITUTE NOVEL COMPREHENSIVE PROTEOME ANALYSES OF METASTASIS Complete
2003 R33 PAR-01-104 LAM, KIT S UNIVERSITY OF CALIFORNIA DAVIS SMALL MOLECULE MICROARRAYS FOR INTRACELLULAR PROTEINS Complete
2006 R44 RFA-CA-06-005 BRADY, ERIK D MICROCOSM, INC. ENHANCED CANCER MICROARRAY Complete
2009 R21 RFA-CA-08-009 THOMAS, NANCY E UNIV OF NORTH CAROLINA CHAPEL HILL DNA-METHYLATION PROFILING FROM FIXED MELANOCYTIC TISSUES Complete
2013 R21 RFA-CA-13-001 WILSON, JAMES NORBERT UNIVERSITY OF MIAMI CORAL GABLES KINASE BINDING FLUORESCENT PROBES FOR ASSAYING CELLULAR RECEPTOR POPULATIONS Complete
2016 R33 RFA-CA-15-005 SOKER, SHAY WAKE FOREST UNIVERSITY HEALTH SCIENCES BIOENGINEERED LUNG TUMOR ORGANOIDS FOR DEVELOPMENT OF PERSONALIZED MEDICINE Complete
2000 R33 PAR-99-100 CONTAG, CHRISTOPHER H STANFORD UNIVERSITY VISIBLE ANIMAL MODELS OF NEOPLASTIC DISEASE Complete
2002 R43 PAR-99-101 HENKENS, ROBERT W ALDERON BIOSCIENCES, INC. INNOVATIVE TECHNOLOGY FOR GENE EXPRESSION STUDIES Complete
2006 R21 RFA-CA-06-002 FARIS, GREGORY W SRI INTERNATIONAL DROPLET CELL ARRAY ASSAYS Complete
2008 R44 RFA-CA-07-039 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2012 R21 RFA-CA-12-002 CARON, MARC G. DUKE UNIVERSITY A CANCER RAINBOW MOUSE FOR THE SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES Complete
2015 R43 PAR-13-327 SARAF, RAVI VAJRA INSTRUMENTS, INC. PROFILING CIRCULATING MIRNA WITHOUT PCR FOR EARLY DETECTION OF PANCREATIC CANCER Complete
2000 R21 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2002 R21 PAR-99-100 CLEVELAND, WILLIAM L ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS ROBOTIC PREPARATION OF CDNA SINGLE CELLS Complete
2005 R21 RFA-CA-05-003 OLIVI, ALESSANDRO JOHNS HOPKINS UNIVERSITY "ENHANCEMENT OF BRAIN TUMOR IMMUNOTHERAPY BY FAS-L RNAI" Complete
2008 R21 RFA-CA-07-033 CHAPUT, JOHN CHARLES ARIZONA STATE UNIVERSITY-TEMPE CAMPUS A HIGH-THROUGHPUT ROUTE TO SYNTHETIC ANTIBODIES FOR ARRAY-BASED CANCER DETECTION Complete
2011 R21 RFA-CA-10-005 MESSMER, BRADLEY T UNIVERSITY OF CALIFORNIA SAN DIEGO MOLECULAR EVOLUTION OF MULTIFUNCTIONAL DNA NANOPARTICLES Complete
2015 R21 RFA-CA-14-003 PATTI, GARY JOSEPH WASHINGTON UNIVERSITY CELL-SPECIFIC ISOTOPE LABELING TO TRACK INTERCELLULAR METABOLITE EXCHANGE IN CANCER Complete
1999 R43 PAR-98-066 MOSTERT, MICHAEL J ECHELON BIOSCIENCES, INC. PHOSPHOINOSITIDE 3-KINASE ASSAYS IN CANCER DIAGNOSIS Complete
2001 R43 PAR-99-101 PICCOLI, STEVEN P MOLECULAR STAGING, INC. ROLLING CIRCLE AMPLIFICATION ANALYSIS OF CERVICAL CELLS Complete
2004 R33 PAR-01-106 ZANGAR, RICHARD C BATTELLE PACIFIC NORTHWEST LABORATORIES PROTEOMIC IDENTIFICATION OF NAF BIOMARKERS Complete
2018 R33 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors NCE
2017 R33 RFA-CA-16-004 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip NCE
2018 R33 RFA-CA-17-011 KONRY, TANIA TALI NORTHEASTERN UNIVERSITY Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform NCE
2017 R33 RFA-CA-16-004 PATTENDEN, SAMANTHA GAIL UNIV OF NORTH CAROLINA CHAPEL HILL The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues NCE
2018 R33 RFA-CA-17-011 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH High-throughput super-resolution imaging of chromatin structures at different epigenetic states NCE
2018 R33 RFA-CA-17-011 LU, JUN YALE UNIVERSITY CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer NCE
2017 R33 RFA-CA-16-004 ZILBERBERG, JENNY HACKENSACK UNIVERSITY MEDICAL CENTER Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells NCE
2016 R21 RFA-CA-15-002 GAMCSIK, MICHAEL NORTH CAROLINA STATE UNIVERSITY RALEIGH HIGH-THROUGHPUT SCREENING UNDER STATIC OR DYNAMIC HYPOXIA NCE
2018 R33 RFA-CA-17-011 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods NCE
2018 R21 RFA-CA-17-012 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome NCE
2016 R33 RFA-CA-15-003 WEISS, GREGORY A. UNIVERSITY OF CALIFORNIA-IRVINE Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors NCE
2017 R33 RFA-CA-16-002 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes NCE
2016 R33 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma NCE
2017 R33 RFA-CA-16-002 IBRAHIM, YEHIA BATTELLE PACIFIC NORTHWEST LABORATORIES High Resolution High Throughput Proteomics Platform for Cancer Research NCE
2017 R33 RFA-CA-16-002 WALTER, MATTHEW J WASHINGTON UNIVERSITY TARGETED SINGLE-MOLECULE SEQUENCING ASSAY INCORPORATING MOLECULAR BARCODES NCE
2017 R33 RFA-CA-16-002 PARKER, LAURIE L. UNIVERSITY OF MINNESOTA Fluorescence lifetime-based single fluorophore biosensors of post-translational modification enzyme activity NCE
2017 R21 RFA-CA-16-001 EASWARAN, HARIHARAN JOHNS HOPKINS UNIVERSITY High-efficiency microfluidic-assisted single-cell DNA methylome sequencing NCE
2017 R21 RFA-CA-16-001 MOHS, AARON M. UNIVERSITY OF NEBRASKA MEDICAL CENTER Tunable Fluorescent Organic Nanoparticles for Cancer Imaging Applications NCE
2017 R21 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS NCE
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations NCE
2018 R21 RFA-CA-17-010 FIELDS, RYAN C WASHINGTON UNIVERSITY Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment NCE
2017 R21 RFA-CA-16-001 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Engineered regulation of tyrosine phosphatase activity in living cells NCE
2017 R21 RFA-CA-16-001 BROCK, AMY UNIVERSITY OF TEXAS, AUSTIN High resolution cell lineage tracking and isolation NCE
2019 R21 RFA-CA-18-002 HUANG, XIAOHUA UNIVERSITY OF CALIFORNIA, SAN DIEGO Technology for measuring telomere length of individual chromosomes of single cancer cells NCE
2018 R21 RFA-CA-17-010 KARGINOV, ANDREI V UNIVERSITY OF ILLINOIS AT CHICAGO Optogenetic tools for the dissection of oncogenic signaling mediated by kinases NCE
2018 R21 RFA-CA-17-010 MEHTA, ANAND S MEDICAL UNIVERSITY OF SOUTH CAROLINA Glyco-typer: an antibody capture glycan imaging methodology NCE
2018 R21 RFA-CA-17-010 ROBLES, FRANCISCO E GEORGIA INSTITUTE OF TECHNOLOGY Stimulated Raman scattering spectroscopic optical coherence tomography (SRS-SOCT) for label-free molecular imaging of brain tumor pathology NCE

Pages